Litcius/Paper detail

Synthesis and antiproliferative screening of novel doubly modified colchicines containing urea, thiourea and guanidine moieties

Julia Krzywik, Ewa Maj, Anna Nasulewicz‐Goldeman, Witold Mozga, Joanna Wietrzyk, Adam Huczyński

2021Bioorganic & Medicinal Chemistry Letters22 citationsDOIOpen Access PDF

Abstract

A new series of 10-demethoxy-10-methylaminocolchicines bearing urea, thiourea or a guanidine moieties at position C7 has been designed, synthesized and evaluated for in vitro anticancer activity against different cancer cell lines (A549, MCF-7, LoVo, LoVo/DX). The majority of the new derivatives were active in the nanomolar range and were characterized by lower IC50 values than cisplatin or doxorubicin. Two ureas (4 and 8) and thioureas (19 and 25) were found to be good antiproliferative agents (low IC50 values and high SI) and could prove to be promising candidates for further research in the field of anticancer drugs based on the colchicine skeleton.

Topics & Concepts

ThioureaChemistryColchicineGuanidineCisplatinUreaDoxorubicinStereochemistryIC50In vitroCombinatorial chemistryBiochemistryOrganic chemistryChemotherapySurgeryInternal medicineMedicineSynthesis and biological activitySynthesis and Biological EvaluationSynthesis of heterocyclic compounds
Synthesis and antiproliferative screening of novel doubly modified colchicines containing urea, thiourea and guanidine moieties | Litcius